SEC Form D · filed July 15, 2019
Kronos Bio, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (16)
Rebecka C. Belldegrun, M.D · New York, NYDirectorNorbert Bischofberger, Ph.D · New York, NYExec · DirectorJohn C. Martin, Ph.D · New York, NYDirectorDavid M. Tanen · San Francisco, CAExec · Director · PromoterSean A. Algeo · San Mateo, CAExecArie S. Belldegrun, M.D · South San Francisco, CADirectorJacob C. Loven · San Mateo, CADirectorRebecka C. Belldegrun, M.D · New York, NYDirectorNorbert Bischofberger, Ph.D · New York, NYExec · DirectorJohn C. Martin, Ph.D · New York, NYDirectorPhilip C. Gutry · San Mateo, CAExecDavid M. Tanen · New York, NYExec · Director · PromoterSean A. Algeo · San Diego, CAExecJoshua A. Kazam · San Francisco, CADirectorOtello C. Stampacchia, Ph.D · New York, NYDirectorArie S. Belldegrun, M.D · Flemington, NJDirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗